|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||34.58 / 51.65|
Here's a look back at how my recommendations worked out.
The planned acquisition of The Medicines Company by Novartis spurs prospects of other deals in the drug business.
Robinhood is bringing a whole new generation of traders into the fold.
Unlike most others, I saw AMTD's huge drop as a buying opportunity, and now look at how it turned out.
* A broad-based gain today * There is a narrative for every Deal and every Bull Market -- but it always changes and sometimes it's faux (e.g. Schwab/TD Ameritrade) The steady and relentless market advance of the last seven weeks continued today. We ...
We're seeing lots of companies snapping up their peers, and the market is applauding.
Buying stocks of Charles Schwab and TD Ameritrade worked out well, after the surge on Nov. 21 when it was announced that Schwab is in serious negotiations to buy AMTD.
With the potential TD Ameritrade deal, clearly E*Trade will not be 'talking to Chuck.'
I would not trade either Schwab or Ameritrade on the long side for fear of a possible antitrust issue.
Citigroup and Lululemon are on the radar this morning.
Tomorrow morning we have several financials reporting their quarterly results before the market open: Charles Schwab Citigroup Goldman Sachs JP Morgan Chase Wells Fargo What I've noticed is expectations for both Goldman as well as Morgan Stanley , w...
Commissions do cut into the customer's profits, so now with that removed we may see trading come alive even more with options.
The stock's fall following online broker wars that sent stock commissions to zero was way overdone.
When you're the most bummed out about how much you've lost, so is everybody else, and that's when they're willing to part with even the best stocks at really low prices.
These guys are going to make a lot of money by moving to this route.
As these three big discount brokers move to commission-free trading on certain products, how will they make a profit? And are they now a buy?
TD Ameritrade is poised to offer big returns at a low entry point.
Are things that bad? I remain a non-believer in the recession thesis.
Charles Schwab has announced it will eliminate commissions for stocks, ETFs and options listed on U.S. or Canadian exchanges. In response we are seeing shares of TD Ameritrade , E-Trade , Interactive Brokers and Schwab trade off in pre-market tradi...
At lower prices, SCHW looks more attractive than ever, so consider buying some LEAP call options.
Charles Schwab appears headed into another record year, yet the stock had fallen to just over $40 -- that pullback smells like opportunity.
For those trading the FANG or FAANG names, and especially Facebook, Tuesday sets up as a day bearing exceptional levels of headline risk.
Schwab, Domino's, Netflix and UnitedHealth are set to report their quarterly results.